German Version French Version

Olanzapine Olanzapine, 2-Methyl-10-(4-methylpiperazin-1-yl)-4H-3-thia-4,9-diazabenzo[f]azulene
C17H20N4S, M=312.44 g/mol

atypical antipsychotic

Trade Mark: Zyprexa


Treatment of schizophrenia and bipolar mania. Initial dose 10 mg, thereafter 20 mg. The maximum level is reached after 5-8 hours, half-life 21 up to 54 hours.


Do not use with older dementia patients as well as cases of glaucoma.


Accelerated metabolism with simultaneous use of Carbamazepine, slowed down metabolisms with Fluvoxamine.

Adverse Effects

Substantial weight gain with increased diabetic risk, since Olanzapine intervenes in the insulin metabolism.


Therapeutic levels: 0.02 up to 0.03 µg/ml (serum/plasma).

Custom Search




Last modification (M-D-Y): 02/08/2019 - IMPRINT - FAQ